Prothena Past Performance
How has Prothena performed over the past 5 years?
[object Object] Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PRTA is currently unprofitable.
Growing Profit Margin: PRTA is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: PRTA is unprofitable, but has reduced losses over the past 5 years at a rate of 32.6% per year.
Accelerating Growth: Unable to compare PRTA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PRTA is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (60.8%).
Return on Equity
High ROE: PRTA has a negative Return on Equity (-38.67%), as it is currently unprofitable.